School of Medicine


Showing 71-77 of 77 Results

  • Michael Spinner

    Michael Spinner

    Instructor, Medicine - Oncology

    Bio Dr. Spinner received his undergraduate degree in music (classical guitar performance) from Emory University, received his medical degree from Vanderbilt, and completed his internal medicine residency and hematology/oncology fellowship at Stanford. During medical school, Michael participated in the NIH Medical Research Scholars Program, working with Dr. Steven Holland on characterizing a novel immunodeficiency and bone marrow failure disorder resulting from inherited GATA2 mutations (GATA2 deficiency). This work led to a new clinical protocol to better understand the natural history of GATA2 deficiency, a highly cited publication in Blood, and an NIH Merit Award for outstanding clinical research. At Stanford under the mentorship of Drs. Ranjana Advani, Robert Lowsky, and Peter Greenberg, Michael's research has focused on therapeutic clinical trials for patients with blood cancers, including studies of novel immunotherapies, cell therapies, and precision medicine approaches to inform rational drug selection and personalized treatment. Under Dr. Advani?s mentorship, Michael has developed a particular interest and expertise in Hodgkin and non-Hodgkin lymphomas and the use of novel immunotherapies and precision medicine approaches to treat these disorders. After completing his fellowship training in June 2020, Michael will transition to an Instructor in the Division of Oncology at Stanford, where he will focus on patient care and clinical trials for patients with lymphoma. Outside of medicine, Michael is an avid classical guitarist with a passion for classical music and jazz.

  • Sandy Srinivas

    Sandy Srinivas

    Professor of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Clinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma

  • Frank E. Stockdale

    Frank E. Stockdale

    Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus

    Current Research and Scholarly Interests Laboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth

  • Melinda L. Telli, M.D.

    Melinda L. Telli, M.D.

    Associate Professor of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests My research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.

  • Haluk Tezcan, MD

    Haluk Tezcan, MD

    Adjunct Clinical Assistant Professor, Medicine - Oncology

    Bio Clinical focus:
    Breast Oncology
    Molecular Diagnostics

    Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.

    He is leading the development of Lexent Bio's liquid biopsy technology, first in response monitoring, overseeing scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director both in academia and private practice, he has firsthand understanding of unmet clinical needs of physicians and patients, and broad experience in clinical trial design and implementation.
    He established the CA.RE.foundation, a cancer research foundation dedicated to enabling clinical trial execution across community oncology sites throughout the Northwest US. He?s independently built multiple software tools to help oncologists in the practical realities of their daily work.

    Before Lexent Bio, he has served as Director of Translational Medicine at Genomic Health and as Vice President leading oncology development at Counsyl, integrating science with clinical product development. He is a steering committee member of the ASCO QOPI, a quality care initiative.

  • Felipe Vences Catalan

    Felipe Vences Catalan

    Instructor, Medicine - Oncology

    Current Research and Scholarly Interests My current research focuses on understanding the biology of cancer, more specifically how Tetraspanin molecules contribute to the development and spread of cancer. I am also interested in unraveling the interaction of immune cells in the tumor microenvironment and how we can use immunotherapy to treat lymphoma and breast cancer aiming towards translational medicine.

  • Heather Wakelee

    Heather Wakelee

    Professor of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Wakelee's research is focused on clinical trials and translational efforts in patients with lung cancer and other thoracic malignancies such as thymoma and thymic carcinoma. Other interests include translation projects in thoracic malignancies and collaborations with population scientists regarding lung cancer questions.

Footer Links:

Stanford Medicine Resources: